Association of fludarabin, cytarabine, and fractioned gemtuzumab followed by hematopoietic stem cell transplantation for first-line refractory acute myeloid leukemia in children: A single-center experience.

Mathilde Penel-PageAdriana PlesaSandrine GirardAlice Marceau-RenautCécile RenardYves Bertrand

Published in: Pediatric blood & cancer (2020)

FLA-GO is a good salvage regimen for pediatric refractory AML, with significant but acceptable toxicity. HSCT is mandatory to achieve sustained CR in these patients.

Keyphrases

acute myeloid leukemia
end stage renal disease
allogeneic hematopoietic stem cell transplantation
chronic kidney disease
ejection fraction
newly diagnosed
young adults
peritoneal dialysis
prognostic factors
oxidative stress
high dose